Upon further thought, we know Mr. Rae knows the ins and outs of LL *and* Cytodyn from his previous tenure. Would this man - who has a stellar resume and a law degree - return to Cytodyn if it was in the sh!tter? No he would not. He would not return unless there was work to be done, business to develop, and opps to license.

Quote:

---

His previous title was "Senior Vice President Business Development"

His current title is "Senior Vice President Licensing and Business Development"

Note the addition of "Licensing."

Licensing definition: In the pharmaceutical industry, licensing is the transfer of rights to a third party (the Licensee) to use the Intellectual Property owned by an innovator (the Licensor) under mutually agreed terms and conditions.

Maybe I've overthought this. Maybe I haven't.

Quote:
Add me to the list of those that appreciate having Brendan Rae back. He grew up with about 7 years in big pharma. Has a law degree. Was at CYDY for over a year ending August 2020, then appears to have become US bus dev head for a major Chinese generic maker that also mentions biosimilars - so MABs.

---